OCULIS HOLDING AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.07 USD | +0.88% |
|
-5.70% | +7.48% |
| May. 08 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | H.C. Wainwright Adjusts Price Target on Oculis Holding to $28 From $29, Keeps Buy Rating | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 153.1 | 345.7 | 455.9 | - | - |
| Enterprise Value (EV) 1 | 153.1 | 254 | 375.9 | 430.7 | 462.5 |
| P/E ratio | -0.72 x | -3.18 x | -7.07 x | -6.13 x | -6.34 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 391 x | 499 x | 41.8 x | 13.6 x |
| EV / Revenue | - | 288 x | 411 x | 39.5 x | 13.8 x |
| EV / EBITDA | - | - | -6.83 x | -11.4 x | 60.9 x |
| EV / FCF | - | - | -7.81 x | -8.83 x | -5.04 x |
| FCF Yield | - | - | -12.8% | -11.3% | -19.8% |
| Price to Book | - | 3.69 x | 3.56 x | 4.99 x | 4.66 x |
| Nbr of stocks (in thousands) | 16,399 | 36,598 | 41,650 | - | - |
| Reference price 2 | 9.336 | 9.445 | 10.94 | 10.94 | 10.94 |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.883 | 0.914 | 10.9 | 33.59 |
| EBITDA 1 | - | - | -55.06 | -37.74 | 7.594 |
| EBIT 1 | - | -80.71 | -56.16 | -64.14 | -41.9 |
| Operating Margin | - | -9,140.88% | -6,144.18% | -588.6% | -124.71% |
| Earnings before Tax (EBT) 1 | - | -88.7 | -71.54 | -71.88 | -66.7 |
| Net income 1 | -38.7 | -88.8 | -58.11 | -72.76 | -74.73 |
| Net margin | - | -10,056.85% | -6,358.03% | -667.64% | -222.45% |
| EPS 2 | -12.94 | -2.970 | -1.548 | -1.786 | -1.726 |
| Free Cash Flow 1 | - | - | -48.1 | -48.8 | -91.7 |
| FCF margin | - | - | -5,262.81% | -447.8% | -272.96% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.25 | - | 0.219 | 0.185 | 0.222 | 0.2411 | 0.236 | 0.2088 |
| EBITDA | - | - | -12.89 | - | - | - | - | - |
| EBIT 1 | -10.74 | - | -12.96 | -12.18 | -15.33 | -14.38 | -14.79 | -15.78 |
| Operating Margin | -4,298% | - | -5,917.35% | -6,585.95% | -6,904.5% | -5,962.01% | -6,267.85% | -7,559.79% |
| Earnings before Tax (EBT) 1 | -12.76 | - | -17.53 | -12.51 | -16.06 | -16.72 | -18.44 | -20.32 |
| Net income 1 | -12.88 | - | -17.41 | -12.5 | -16.09 | -14.05 | -14.76 | -15.6 |
| Net margin | -5,150.8% | - | -7,951.14% | -6,756.22% | -7,249.1% | -5,826.84% | -6,256.45% | -7,472.3% |
| EPS 2 | -0.3800 | -2.530 | -0.4800 | -0.3400 | -0.4400 | -0.3802 | -0.3942 | -0.3998 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 8/29/23 | 8/29/23 | 11/15/23 | 3/18/24 | 5/8/24 | - | - | - |
1CHF in Million2CHF
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 6.69 |
| Net Cash position 1 | - | 91.7 | 80 | 25.1 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | 0.8805 x |
| Free Cash Flow 1 | - | - | -48.1 | -48.8 | -91.7 |
| ROE (net income / shareholders' equity) | - | - | -80.6% | - | 6.86% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | 2.560 | 3.070 | 2.190 | 2.350 |
| Cash Flow per Share 2 | - | - | -1.990 | -2.470 | - |
| Capex 1 | - | - | 0.4 | 0.4 | 0.4 |
| Capex / Sales | - | - | 43.77% | 3.67% | 1.19% |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
10.94
CHF
Average target price
25.58
CHF
Spread / Average Target
+133.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.48% | 503M | |
| +17.96% | 44.96B | |
| +48.77% | 41.85B | |
| +1.17% | 42.65B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- OCS Stock
- Financials Oculis Holding AG